These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20863212)

  • 1. Recombinant human erythropoietin treatment protects the cardio-renal axis in a model of moderate chronic renal failure.
    Teixeira AM; Garrido P; Santos P; Alves R; Parada B; Costa E; Almeida A; Teixeira-Lemos E; Sereno J; Pinto R; Belo L; Santos-Silva A; Teixeira F; Reis F
    Ren Fail; 2010; 32(9):1073-80. PubMed ID: 20863212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
    Rodrigue ME; Lacasse-M S; Larivière R; Lebel M
    Can J Physiol Pharmacol; 2005 Jun; 83(6):467-75. PubMed ID: 16049546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a rat model of moderate chronic renal failure--focus on hematological, biochemical, and cardio-renal profiles.
    Garrido P; Reis F; Costa E; Teixeira-Lemos E; Parada B; Alves R; Piloto N; Sereno J; Figueiredo A; Pinto R; Carvalho L; Rocha-Pereira P; Belo L; Santos-Silva A; Teixeira F
    Ren Fail; 2009; 31(9):833-42. PubMed ID: 19925293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment.
    Lisowska KA; Debska-Slizień A; Bryl E; Rutkowski B; Witkowski JM
    Artif Organs; 2010 Aug; 34(8):654-62. PubMed ID: 20528849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of TGF-beta1 antisense oligodeoxynucleotide on renal function in chronic renal failure rats.
    Hiong LC; Voon KL; Abdullah NA; Sattar MA; Rahman NA; Khan AH; Johns EJ
    Acta Pharmacol Sin; 2008 Apr; 29(4):451-7. PubMed ID: 18358091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaemia, iron studies and erythropoietin in patients of chronic renal failure.
    Singh NP; Aggarwal L; Singh T; Anuradha S; Kohli R
    J Assoc Physicians India; 1999 Mar; 47(3):284-90. PubMed ID: 10999121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
    Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
    Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for erythropoietin synthesis in kidney of uraemic rat alters depending on severity of renal failure.
    Sanada S; Toyama H; Ejima Y; Matsubara M
    Nephrology (Carlton); 2009 Dec; 14(8):735-42. PubMed ID: 20025682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological and molecular mechanisms underlying resistance to recombinant human erythropoietin therapy in the remnant kidney rat model of chronic kidney disease associated anemia.
    Ribeiro S; Garrido P; Fernandes J; Vala H; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
    Biochimie; 2016 Jun; 125():150-62. PubMed ID: 27039028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition.
    Park SH; Choi MJ; Song IK; Choi SY; Nam JO; Kim CD; Lee BH; Park RW; Park KM; Kim YJ; Kim IS; Kwon TH; Kim YL
    J Am Soc Nephrol; 2007 May; 18(5):1497-507. PubMed ID: 17389738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects erythropoietin on experimental anemia in rats with chronic renal failure].
    Ling SS; Zhou Y; Sun WL; Zhu DC; Zhang HY; Tang GZ; Jin YF; Zhu JZ
    Yao Xue Xue Bao; 1992; 27(6):412-7. PubMed ID: 1442067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoetin delta as an antifibrotic agent in the remnant kidney rat: a possible role for transforming growth factor beta and hepatocyte growth factor.
    De Beuf A; D'Haese PC; Verhulst A
    Nephron Exp Nephrol; 2010; 115(3):e46-59. PubMed ID: 20424483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic renal failure on the expression of erythropoietin message in a murine model.
    Zhang F; Laneuville P; Gagnon RF; Morin B; Brox AG
    Exp Hematol; 1996 Nov; 24(13):1469-74. PubMed ID: 8950229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat.
    Teixeira M; Rodrigues-Santos P; Garrido P; Costa E; Parada B; Sereno J; Alves R; Belo L; Teixeira F; Santos-Silva A; Reis F
    J Pharm Bioallied Sci; 2012 Jan; 4(1):76-83. PubMed ID: 22368404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?
    Srisawat N; Manotham K; Eiam-Ong S; Katavetin P; Praditpornsilpa K; Eiam-Ong S
    Int J Urol; 2008 Oct; 15(11):1011-7. PubMed ID: 18759748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.